STOCK TITAN
  1. Home
  2. Sec-filings
  3. ASTH
  4. [Form 4] Astrana Health, Inc. Insider Trading Activity

Astrana Health (ASTH) director receives 4,525 restricted stock award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Dong Linda reported acquisition or exercise transactions in this Form 4 filing.

Astrana Health, Inc. director Linda Dong received an equity award of 4,525 shares of restricted common stock. The grant was made under the company’s 2024 Equity Incentive Plan. These restricted shares will vest on the earlier of June 10, 2027 or the company’s 2027 annual meeting of stockholders. Following this grant, Dong directly holds 97,133 shares of Astrana Health common stock, including the unvested restricted shares.

Positive

  • None.

Negative

  • None.
Insider Dong Linda
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 4,525 $0.00 --
Holdings After Transaction: Common Stock — 97,133 shares (Direct)
Footnotes (1)
  1. Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.
Restricted stock grant 4,525 shares Award of common stock to director Linda Dong
Grant price per share $0.00 per share Reported acquisition price for restricted shares
Total holdings after grant 97,133 shares Direct ownership by Linda Dong following transaction
Vesting date trigger June 10, 2027 Latest vesting date for restricted stock
Restricted shares financial
"Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan"
Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.
2024 Equity Incentive Plan financial
"granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027"
restricted stock financial
"Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
annual meeting of stockholders financial
"the date of the Issuer's 2027 annual meeting of stockholders"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transaction did Astrana Health (ASTH) report for Linda Dong?
Astrana Health reported that director Linda Dong received 4,525 shares of restricted common stock as an equity award. The shares were granted at no cash cost under the company’s 2024 Equity Incentive Plan, reflecting routine board-level compensation.

When do Linda Dong’s new Astrana Health (ASTH) restricted shares vest?
The 4,525 restricted shares granted to Linda Dong vest on the earlier of June 10, 2027 or Astrana Health’s 2027 annual meeting of stockholders. This time-based vesting encourages continued board service through that future date or meeting.

How many Astrana Health (ASTH) shares does Linda Dong hold after this Form 4?
After the award, Linda Dong directly holds 97,133 shares of Astrana Health common stock. This figure includes the 4,525 restricted shares subject to vesting on the earlier of June 10, 2027 or the company’s 2027 annual stockholder meeting.

Was Linda Dong’s Astrana Health (ASTH) Form 4 a purchase or a grant?
The Form 4 reflects a grant or award, not an open-market purchase. Linda Dong acquired 4,525 restricted shares of common stock with a reported price of $0.00 per share as compensation under Astrana Health’s 2024 Equity Incentive Plan.

What plan governs Linda Dong’s new Astrana Health (ASTH) restricted stock award?
The award was granted under Astrana Health’s 2024 Equity Incentive Plan. This plan authorizes equity-based compensation, including restricted stock, for eligible participants such as directors, with vesting terms like those applied to Linda Dong’s 4,525-share grant.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dong Linda
(Last)(First)(Middle)
C/O ASTRANA HEALTH, INC.
1668 S. GARFIELD AVE, 2ND FLOOR
(Street)
ALHAMBRA CALIFORNIA 91801
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Astrana Health, Inc. [ ASTH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/10/2026A4,525(1)A$097,133(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.
2. Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.
/s/ Kathy Diep, as Attorney-in-Fact06/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR